However, upon challenge with the tumour target cells YAC-1 and V-abl21, loss of HIF-1α reduced the fraction of CD107A-positive and IFN-γ-positive NK cells in normoxia and hypoxia (Fig. 1b, c). This evidence concerns the gene HIF1A and neoplasm.